Viewing Study NCT00836160


Ignite Creation Date: 2025-12-25 @ 2:08 AM
Ignite Modification Date: 2025-12-26 @ 4:05 PM
Study NCT ID: NCT00836160
Status: COMPLETED
Last Update Posted: 2012-09-20
First Post: 2009-02-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Comparing Efficacy Between Anti-microtubule and Non-anti-microtubule as 3th Therapy After 2nd Line EGFR-TKI Therapy
Sponsor: AstraZeneca
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module